Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study - Archive ouverte HAL Access content directly
Journal Articles European Psychiatry Year : 2021

Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study

(1) , (2, 3) , (4) , (5) , (6, 7) , (8) , (9) , (1) , (10, 11)
1
2
3
4
5
6
7
8
9
10
11

Abstract

Background: Patients with schizophrenia spectrum disorders (SSD) have worse physical health and reduced life expectancy compared to the general population. In 2009, the European Psychiatric Association, the European Society of Cardiology and the European Association for the Study of Diabetes published a position paper aimed to improve cardiovascular and diabetes care in patients with severe mental illnesses. However, the initiative did not produce the expected results. Experts in SSD or in cardiovascular and metabolic diseases convened to identify main issues relevant to management of cardiometabolic risk factors in schizophrenia patients and to seek consensus through the Delphi method. Methods: The steering committee identified four topics: 1) cardiometabolic risk factors in schizophrenia patients; 2) cardiometabolic risk factors related to antipsychotic treatment; 3) differences in antipsychotic cardiometabolic profiles; 4) management of cardiometabolic risk. Twelve key statements were included in a Delphi questionnaire delivered to a panel of expert European psychiatrists. Results: Consensus was reached for all statements with positive agreement higher than 85% in the first round. European psychiatrists agreed on: 1) high cardiometabolic risk in patients with SSD, 2) importance of correct risk management of cardiometabolic diseases, from lifestyle modification to treatment of risk factors, including the choice of antipsychotic drugs with a favourable cardiometabolic profile. The expert panel identified the psychiatrist as the central coordinating figure of management, possibly assisted by other specialists and general practitioners. Conclusions: This study demonstrates high level of agreement among European psychiatrists regarding the importance of cardiovascular risk assessment and management in subjects with SSD.
Fichier principal
Vignette du fichier
Galderisi et al Eur Psychiatry. 2021.pdf (168.28 Ko) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

inserm-03280472 , version 1 (07-07-2021)

Identifiers

Cite

Silvana Galderisi, Marc de Hert, Stefano del Prato, Andrea Fagiolini, Philip Gorwood, et al.. Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study. European Psychiatry, 2021, 64 (1), pp.e7. ⟨10.1192/j.eurpsy.2020.115⟩. ⟨inserm-03280472⟩
18 View
51 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More